Onkos Molecular Diagnostics

We develop and perform proprietary gene expression profiling AI-based molecular classifiers tests in Oncology. We are Latin America leaders on Thyroid molecular tests with our very own family of mir-THYpe tests. The mir-THYpe full is a molecular test for indeterminate thyroid nodules which has already impacted more than 4.500 patients in Latam and can reduce up to 75% of unnecessary surgeries, making our affordable test a cost effective option to health systems. Science, Evidence & True Impact

Molecular diagnostics,gene expression profiling,and oncology

Onkos molecular diagnostics operates in the Medical and diagnostic laboratories industry.

Onkos molecular diagnostics's revenue is 11m - 100m

Onkos molecular diagnostics has 11 - 50 employees.